-
1
The estimated number of US residents with chronic respiratory disease rose from 33.28 million in 1990 to 54.5 million in 2023.
-
2
From 1990 to 2023, age-standardized prevalence increased 10.24%, and age-standardized mortality rose from 19 to 34.56 deaths per 100,000.
-
3
Age-standardized mortality declined for asthma and pneumoconiosis but increased for COPD and interstitial lung disease with pulmonary sarcoidosis.
-
4
Modifiable risk factors accounted for 44.54% of chronic respiratory disease DALYs; high BMI led asthma burden, smoking led COPD burden, and occupational asthmagen exposure led pneumoconiosis burden.
-
5
By 2050, age-standardized prevalence is projected to rise for asthma and interstitial lung disease with pulmonary sarcoidosis, but decline for COPD and pneumoconiosis.